Exhibit 99.2

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended
	March 31,
	2006			2005
Revenue	$	339,119		$	303,934
Costs and expenses:
Cost of operations		195,267			172,163
Development and engineering		14,914			14,640
Sales, marketing, general and administrative		88,832			82,137
Depreciation and amortization		18,928			16,504
Legal expense		542			4,160
Loss on investments		—			3,832
Interest income		4,419			4,321
Interest expense		4,691			4,781
Income before income tax provision and minority interest		20,364			10,038
Income tax provision		4,562			189
Minority interest in WebMD Health Corp., net of tax		(629	)		—
Net income	$	16,431		$	9,849
Net income per common share:
Basic and diluted	$	0.06		$	0.03
Weighted-average shares outstanding used in computing net income per common share:
Basic		287,195			325,334
Diluted		295,492			335,689

EMDEON CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended
	March 31,
	2006			2005
Revenues
Emdeon Business Services	$	201,154		$	185,733
Emdeon Practice Services		75,706			73,018
WebMD		50,051			33,575
Porex		20,587			19,856
Inter-segment eliminations		(8,379	)		(8,248	)
	$	339,119		$	303,934
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”)
Emdeon Business Services	$	43,193		$	38,253
Emdeon Practice Services		10,173			4,397
WebMD (a)		6,527			3,230
Porex		5,554			5,397
Corporate (a)		(11,274	)		(12,005	)
	$	54,173		$	39,272
Adjusted EBITDA per basic common share (b)	$	0.19		$	0.12
Adjusted EBITDA per diluted common share (b)	$	0.18		$	0.12
Interest, taxes, non-cash and other items (c)
Depreciation and amortization	$	(18,928	)	$	(16,504	)
Amortization of non-cash advertising		(1,605	)		(2,627	)
Non-cash stock-based compensation (d)		(12,462	)		(1,651	)
Legal expense		(542	)		(4,160	)
Loss on investments		—			(3,832	)
Interest income		4,419			4,321
Interest expense		(4,691	)		(4,781	)
Minority interest in WebMD Health Corp., net of tax		629			—
Income tax provision		(4,562	)		(189	)
Net income	$	16,431		$	9,849
Net income per common share:
Basic and diluted	$	0.06		$	0.03
Weighted-average shares outstanding used in computing net income per common share:
Basic		287,195			325,334
Diluted		295,492			335,689

(a)	Adjusted EBITDA during prior periods, for the Corporate and WebMD segments, has been reclassified to conform to the current period presentation.
(b)	Adjusted EBITDA per basic and diluted common share is based on the weighted-average shares outstanding used in computing net income per common share (basic and diluted).
(c)	Reconciliation of Adjusted EBITDA to net income.
(d)	Reflects the adoption of SFAS 123R effective January 1, 2006.

EMDEON CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

	March 31,		December 31,
	2006		2005
	(Unaudited)
Assets
Cash and cash equivalents	$	137,145	$	159,510
Short-term investments		239,653		267,387
Accounts receivable, net		236,057		233,070
Inventory		13,852		14,251
Prepaid expenses and other current assets		33,605		34,615
Total current assets		660,312		708,833
Marketable equity securities		4,265		4,481
Property and equipment, net		120,791		116,032
Goodwill		1,087,731		1,075,549
Intangible assets, net		240,095		240,510
Other assets		49,116		50,278
Total Assets	$	2,162,310	$	2,195,683
Liabilities and Stockholders’ Equity
Accounts payable	$	10,525	$	11,611
Accrued expenses		172,179		186,381
Deferred revenue		125,705		115,840
Total current liabilities		308,409		313,832
Convertible notes		650,000		650,000
Other long-term liabilities		15,372		15,353
Minority interest in WebMD Health Corp.		48,005		43,229
Convertible redeemable exchangeable preferred stock		98,591		98,533
Stockholders’ equity		1,041,933		1,074,736
Total Liabilities and Stockholders’ Equity	$	2,162,310	$	2,195,683

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Three Months Ended
	March 31,
	2006			2005
Cash flows from operating activities:
Net income	$	16,431		$	9,849
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		18,928			16,504
Minority interest in WebMD Health Corp., net of tax		(629	)		—
Amortization of debt issuance costs		728			726
Non-cash advertising		1,605			2,627
Non-cash stock-based compensation		12,462			1,651
Bad debt expense		1,050			2,283
Loss on investments		—			3,832
Reversal of income tax valuation allowance applied to goodwill		2,157			—
Changes in operating assets and liabilities:
Accounts receivable		(2,245	)		(14,122	)
Inventory		446			253
Prepaid expenses and other, net		(710	)		2,812
Accounts payable		(1,133	)		(8,631	)
Accrued expenses and other long-term liabilities		(9,886	)		(106	)
Deferred revenue		7,557			5,279
Net cash provided by operating activities		46,761			22,957
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		166,228			45,846
Purchases of available-for-sale securities		(137,815	)		(2,550	)
Purchases of property and equipment		(14,168	)		(11,892	)
Proceeds received from sale of property and equipment		—			400
Cash paid in business combinations, net of cash acquired		(27,328	)		(70,775	)
Net cash used in investing activities		(13,083	)		(38,971	)
Cash flows from financing activities:
Proceeds from issuance of common stock		10,565			13,170
Purchases of treasury stock		(66,633	)		—
Payments of notes payable and other		(94	)		(63	)
Net cash (used in) provided by financing activities		(56,162	)		13,107
Effect of exchange rates on cash		119			(358	)
Net decrease in cash and cash equivalents		(22,365	)		(3,265	)
Cash and cash equivalents at beginning of period		159,510			46,019
Cash and cash equivalents at end of period	$	137,145		$	42,754